Adlai Nortye Partners with Lilly and Merck KGaA on Phase 1 AN4035 Combination Study

AN4035, a first-in-class investigational pan-RAS(ON) inhibitor-based ADC, will be evaluated as monotherapy and in combination with cetuximab in the ongoing...

October 16, 2026 | Friday | News
Grünenthal and DKSH Expand Asia-Pacific Partnership to Broaden Access to Pain Medicines

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading pr...

September 29, 2026 | Tuesday | News
GCCL Expands Asia-Pacific Clinical Trial Partnerships at ABP 2026

GCCL (Global Clinical Central Lab), a South Korea-based leading provider of clinical trial sample analysis, announced its participation as a Platinum Spo...

September 09, 2026 | Wednesday | News
Perceptra Expands Thai Medical AI Across Asia With Launch of Inspectra MMG

Perceptra Co., Ltd., a Thai startup developing artificial intelligence technology for medical image analysis, has officially announced its entry into ...

August 27, 2026 | Thursday | News
Wave Life Sciences Gains Shareholder Approval for Proposed US Redomiciliation

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform huma...

July 09, 2026 | Thursday | News
Kither Biotech Completes First-in-Human Phase 1 Trial of Inhaled Respiratory Therapy KIT2014

First-in-human Phase 1 study in 56 healthy participants demonstrated KIT2014’s safety and tolerability KIT2014 is being developed as an inhalati...

June 22, 2026 | Monday | News
Building Smarter Clinical Development: Why Early-Phase Strategy Is Now a Competitive Advantage

    As drug development becomes increasingly complex, early-phase clinical trials are taking on a far more strategic role than simply establish...

June 10, 2026 | Wednesday | Interaction
Hongene Biotech Supports SiranBio’s Dual-Target siRNA Program SA1211 with End-to-End CDMO Capabilities

Hongene Biotech Corporation today announced its support of SiranBio’s SA1211 program, a dual-target siRNA candidate for chronic hepatitis B, unders...

May 07, 2026 | Thursday | News
Specialised Therapeutics Secures Australia and Singapore Approval for ZEPZELCA–Tecentriq in ES-SCLC

  ZEPZELCA® (lurbinectedin), in combination with atezolizumab (Tecentriq®), is approved for use in Australia and Singapore as a first-...

April 22, 2026 | Wednesday | News
Thermo Fisher Scientific Partners with PRECISE to Power Singapore’s Landmark SG100K Biobank Study with Integrated Proteomics

  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, \announced a strategic collaboration with Precision Health Research...

April 10, 2026 | Friday | News
Nelipak Opens Asia-Pacific Technical Development Center in Singapore to Accelerate Sterile Packaging Innovation

  Nelipak® Corporation (“Nelipak”), a leading global provider of healthcare packaging solutions, announced the opening of its new Asi...

March 13, 2026 | Friday | News
ImmunoScape Advances Seed And Boost Cancer Therapy Programme With United States Clinical Collaboration

The company also announced a strategic investment from Leonardo DiCaprio ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures an...

March 06, 2026 | Friday | News
Hongene Biotech Secures Gates Foundation Grant to Advance Equitable mRNA Vaccine Manufacturing

Hongene Biotech announced the receipt of a grant from the Gates Foundation to develop high-quality, affordable, and patent-free cap analogs for use ...

January 14, 2026 | Wednesday | News
Antengene Expands XPOVIO® Approval in Malaysia to Relapsed or Refractory DLBCL

Antengene Corporation Limited, a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing fir...

December 18, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close